INBS — Intelligent Bio Solutions Share News
0.000.00%
Last trade - 00:00- $5.27m
- $1.06m
- $4.22m
Brief: Intelligent Bio Solutions Announces Pricing Of $2.2 Million Public Offering
Intelligent Bio slumps after proposed public offering
Brief: Intelligent Bio Solutions Inc. Announces Proposed Public Offering
Brief: Intelligent Bio Solutions Inc Files FDA's Regulatory Submission For Drug Screening Cartridge
Brief: Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results And Operational Highlights
Brief: Intelligent Bio Solutions Inc. Announces Reverse Stock Split
Brief: Intelligent Bio Solutions Inc Announces Global Garden Equipment Manufacturer To Introduce Intelligent Fingerprinting Drug Tests
Brief: Intelligent Bio Solutions Inc - On December 21, Co Entered Into A Securities Purchase Agreement
Brief: Intelligent Bio Solutions Announces Closing Of Private Placement Offering
Brief: Intelligent Bio Solutions Announces Cancellation Of FY 2021 Annual Meeting Of Stockholders
Brief: Intelligent Bio Solutions Inc Reports First Quarter Ending Sept 30 Preliminary Financial Results
Brief: Intelligent Bio Solutions Inc Announces Airline Adopts Fingerprint Drug Screening System
Brief: GBS Inc Initiates Company Name Change To Intelligent Bio Solutions Inc
Advisory: Alert wrongly tagged to Integrated Business Systems and Services withdrawn
Brief: GBS Inc - FY Preliminary Loss Per Share Of $0.57
Brief: GBS Inc Reports Qtrly Loss Per Share $0.57
Brief: GBS Inc Enters Into Exclusivity Agreement For Acquisition Of Unique Point Of Care Diagnostic Screening Technology Focused On Opioids And Drugs Of Abuse
Brief: GBS Inc Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: GBS Inc. Announces Institutional Review Board Approval To Initiate Clinical Trial At Sutter Health Mills-Peninsula Medical Center